PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10818069-3	2000	Sodium salicylate, aspirin, and indomethacin dose-dependently enhanced nitrite production by interleukin (IL)-1beta-stimulated VSMCs at therapeutic plasma concentration ranges.	Sodium Salicylate	0-17	interleukin 1 beta	Rattus norvegicus	93-115	
10818069-8	2000	Our study demonstrates that aspirin and the aspirin-like drugs, sodium salicylate and indomethacin, increase NO synthesis in IL-1beta-stimulated VSMCs by upregulation of iNOS transcription via a 12-LO pathway.	Sodium Salicylate	64-81	interleukin 1 beta	Rattus norvegicus	125-133	
10501189-7	1999	In addition, 17beta-estradiol (10 microM) and sodium salicylate (10 mM) were able to attenuate the increase in interleukin-1beta levels following exposure to 25 microM A beta.	Sodium Salicylate	46-63	interleukin 1 beta	Rattus norvegicus	111-128	
9718067-1	1998	Aspirin and sodium salicylate enhance to a similar extent the production of nitric oxide (NO) in cultured smooth muscle cells following stimulation by interleukin-1beta (IL-1beta).	Sodium Salicylate	12-29	interleukin 1 beta	Rattus norvegicus	151-168	
9718067-1	1998	Aspirin and sodium salicylate enhance to a similar extent the production of nitric oxide (NO) in cultured smooth muscle cells following stimulation by interleukin-1beta (IL-1beta).	Sodium Salicylate	12-29	interleukin 1 beta	Rattus norvegicus	170-178	
9718067-5	1998	Aspirin and sodium salicylate enhance the induction of iNOS expression by IL-1beta.	Sodium Salicylate	12-29	interleukin 1 beta	Rattus norvegicus	74-82	
9718067-7	1998	We investigated the effect of aspirin and sodium salicylate on the response by IL-1beta of VSMCs pretreated with high glucose (25 mM).	Sodium Salicylate	42-59	interleukin 1 beta	Rattus norvegicus	79-87	
9021956-0	1997	The anti-inflammatory drug sodium salicylate inhibits nitric oxide formation induced by interleukin-1beta at a translational step, but not at a transcriptional step, in hepatocytes.	Sodium Salicylate	27-44	interleukin 1 beta	Rattus norvegicus	88-105	
9021956-7	1997	Sodium salicylate markedly inhibited the NO formation induced by IL-1beta, but did not affect NF-kappaB activation and iNOS mRNA induction.	Sodium Salicylate	0-17	interleukin 1 beta	Rattus norvegicus	65-73	
8741165-9	1996	injection of sodium salicylate 15 min prior to interleukin-1 beta administration inhibited the hyperalgesic effect of interleukin-1 beta, but not the analgesic effect.	Sodium Salicylate	13-30	interleukin 1 beta	Rattus norvegicus	118-136	
8924035-6	1996	The IL-1 beta-induced hyperpolarization was completely blocked by concurrent perfusion with sodium salicylate.	Sodium Salicylate	92-109	interleukin 1 beta	Rattus norvegicus	4-13	
1959024-4	1991	The responses to IL-1 beta, but not to IFN alpha, were blocked by sodium salicylate, suggesting the involvement of synthesis of prostaglandins.	Sodium Salicylate	66-83	interleukin 1 beta	Rattus norvegicus	17-26